Allogreffe de cellules souches hématopoïétiques dans la lymphome de Hodgkin, le lymphome du manteau et autres hémopathies lymphoïdes rares : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
| Autor: | Jeremy Delage, Philippe Lewalle, Anne-Claire Gac, Gandhi Damaj, Jérôme Cornillon, Sylvain Chantepie, Stéphanie Nguyen, Remy Dulery, Edgar Jost, Gilles Salles, Jean-Louis Gauthier, Ibrahim Yakoub-Agha, Franck Morschhauser, Mauricette Michallet, Krimo Bouabdallah |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Oncology
Cancer Research medicine.medical_specialty T cell Cell therapy 03 medical and health sciences 0302 clinical medicine Autologous stem-cell transplantation immune system diseases hemic and lymphatic diseases Internal medicine medicine Radiology Nuclear Medicine and imaging business.industry Refractory Disease Haematopoietic cell transplantation Hematology General Medicine medicine.disease Lymphoma medicine.anatomical_structure Novel agents 030220 oncology & carcinogenesis Refractory lymphoma business 030215 immunology |
| Zdroj: | Bulletin du Cancer. 104:S112-S120 |
| ISSN: | 0007-4551 |
| Popis: | Despite great improvements in the outcome of patients with lymphoma, some may still relapse or present with primary refractory disease. In these situations, allogeneic haematopoietic cell transplantation is a potentially curative option, in particular in the case of relapse after autologous stem cell transplantation. Recently, novel agents such as anti-PD1 and BTK inhibitors have started to challenge the use of allogeneic haematopoietic cell transplantation for relapsed or refractory lymphoma. During the 2016 annual workshop of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC), we performed a comprehensive review of the literature published in the last 10 years and established guidelines to clarify the indications and transplant modalities in this setting. This manuscript specifically reports on our conclusions regarding Hodgkin's lymphoma as well as rarer entities, such as T cell lymphomas. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|